Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Medtronic to spin off diabetes business | Stroke care keeps evolving | A key TAVR valve approval | J&J MedTech's new catheter

News You Need to Know Today
Medtronic to spin off diabetes business | Stroke care keeps evolving | A key TAVR valve approval | J&J MedTech's new catheter
Thursday, May 22, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Medtronic to spin off its diabetes business

One of the world's largest medtech companies could make a major move within the next 18 months. Que Dallara, the current president of Medtronic’s diabetes business, would be the new company's CEO.

READ MORE >
spin off spinoff separate business new direction new path
Share on Twitter Share on Facebook Share on Linkedin

Medtronic to spin off its diabetes business

Share on Twitter Share on Facebook Share on Linkedin
spin off spinoff separate business new direction new path
One of the world's largest medtech companies could make a major move within the next 18 months. Que Dallara, the current president of Medtronic’s diabetes business, would be the new company's CEO.
READ MORE >

Stroke care continues to evolve thanks to AI, cardiologists and more

Gregg Fonarow, MD, discussed the American Heart Association's stroke guidelines, the growing influence of AI and much more.

READ MORE >
Video interview with Gregg Fonarow, MD, explaining the success of the AHA Get With The Guidelines-Stroke program, during AHA 2024.
Share on Twitter Share on Facebook Share on Linkedin

Stroke care continues to evolve thanks to AI, cardiologists and more

Share on Twitter Share on Facebook Share on Linkedin
Video interview with Gregg Fonarow, MD, explaining the success of the AHA Get With The Guidelines-Stroke program, during AHA 2024.
Gregg Fonarow, MD, discussed the American Heart Association's stroke guidelines, the growing influence of AI and much more.
READ MORE >

LVOT modification during robotic mitral valve repair limits complications

While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.

READ MORE >
robotic heart surgery cardiac surgeon
Share on Twitter Share on Facebook Share on Linkedin

LVOT modification during robotic mitral valve repair limits complications

Share on Twitter Share on Facebook Share on Linkedin
robotic heart surgery cardiac surgeon
While LVOT modification does make these procedures longer, it can help high-risk patients avoid systolic anterior motion.
READ MORE >

Medtronic gains a key approval for Evolut TAVR valves

More patients can now undergo redo TAVR with a Medtronic valve than ever before.

READ MORE >
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains a key approval for Evolut TAVR valves

Share on Twitter Share on Facebook Share on Linkedin
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
More patients can now undergo redo TAVR with a Medtronic valve than ever before.
READ MORE >

Johnson & Johnson MedTech launches new 2D ICE catheter

The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists. 

READ MORE >
 SoundStar Crystal Ultrasound Catheter Johnson & Johnson MedTech
Share on Twitter Share on Facebook Share on Linkedin

Johnson & Johnson MedTech launches new 2D ICE catheter

Share on Twitter Share on Facebook Share on Linkedin
 SoundStar Crystal Ultrasound Catheter Johnson & Johnson MedTech
The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists. 
READ MORE >

Featured Articles

IVL delivers significant value for women, real-world data confirm

Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.

READ MORE >
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Share on Twitter Share on Facebook Share on Linkedin

IVL delivers significant value for women, real-world data confirm

Share on Twitter Share on Facebook Share on Linkedin
The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.
Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.
READ MORE >

Same-day discharge after TAVR linked to positive outcomes

When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Same-day discharge after TAVR linked to positive outcomes

Share on Twitter Share on Facebook Share on Linkedin
When low-risk patients undergo transfemoral TAVR, they may be able to go home without spending a single night at the hospital.
READ MORE >

Chest tube-clearing device improves recovery, limits readmissions after heart surgery

“Conventional chest tubes are prone to clogging, which can hinder recovery,” one researcher explained. 

READ MORE >
The PleuraFlow Active Clearance Technology (ACT) System from ClearFlow
Share on Twitter Share on Facebook Share on Linkedin

Chest tube-clearing device improves recovery, limits readmissions after heart surgery

Share on Twitter Share on Facebook Share on Linkedin
The PleuraFlow Active Clearance Technology (ACT) System from ClearFlow
“Conventional chest tubes are prone to clogging, which can hinder recovery,” one researcher explained. 
READ MORE >

In Case You Missed It

CCTA shows colchicine's impact on atherosclerosis progression

Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.

READ MORE >
Matthew Budoff explains use of CCTA to track coronary disease plaque progression
Share on Twitter Share on Facebook Share on Linkedin

CCTA shows colchicine's impact on atherosclerosis progression

Share on Twitter Share on Facebook Share on Linkedin
Matthew Budoff explains use of CCTA to track coronary disease plaque progression
Matthew Budoff, MD, detailed new data highlighting CCTA's value when it comes to tracking the progression of coronary atherosclerosis.
READ MORE >

AI-enabled CCTA evaluations reduce use of invasive imaging exams

This two-year analysis of the FISH&CHIPS study found that using advanced AI from Heartflow to evaluate cardiac CT is safe, effective and limits the use of unnecessary follow-up tests.

READ MORE >
An example of HeartFlow's FFR-CT technology, which takes the cardiac CT dataset and uses computational fluid dynamics to create virtual fraction flow reserve values. The FFR measurement can help determine if a coronary lesion is significant enough to require revascularization, or if the patient should be treated with medication. FFR-CT was included as a recommendation in select patients in the 2021 Chest Pain Guidelines.
Share on Twitter Share on Facebook Share on Linkedin

AI-enabled CCTA evaluations reduce use of invasive imaging exams

Share on Twitter Share on Facebook Share on Linkedin
An example of HeartFlow's FFR-CT technology, which takes the cardiac CT dataset and uses computational fluid dynamics to create virtual fraction flow reserve values. The FFR measurement can help determine if a coronary lesion is significant enough to require revascularization, or if the patient should be treated with medication. FFR-CT was included as a recommendation in select patients in the 2021 Chest Pain Guidelines.
This two-year analysis of the FISH&CHIPS study found that using advanced AI from Heartflow to evaluate cardiac CT is safe, effective and limits the use of unnecessary follow-up tests.
READ MORE >

Rates of obesity, high blood pressure and diabetes keep climbing in US

As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. "Our findings highlight the urgent need for targeted strategies to reduce state-based inequities in cardiometabolic risk factors,” researchers wrote. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Rates of obesity, high blood pressure and diabetes keep climbing in US

Share on Twitter Share on Facebook Share on Linkedin
As time goes on, the gaps between the healthiest states and the least healthy states are only getting wider and wider. "Our findings highlight the urgent need for targeted strategies to reduce state-based inequities in cardiometabolic risk factors,” researchers wrote. 
READ MORE >

In Other News

AI newswatch: American AI in the United Arab Emirates, healthcare AI investment, med schools embrace AI, more

Here’s a big thing to watch for in the wake of the President’s flashy Middle East tour: the AI “acceleration partnership” between the U.S. and the United Arab Emirates. 

READ MORE >
Trump United Arab Emirates AI deal
Share on Twitter Share on Facebook Share on Linkedin

AI newswatch: American AI in the United Arab Emirates, healthcare AI investment, med schools embrace AI, more

Share on Twitter Share on Facebook Share on Linkedin
Trump United Arab Emirates AI deal
Here’s a big thing to watch for in the wake of the President’s flashy Middle East tour: the AI “acceleration partnership” between the U.S. and the United Arab Emirates. 
READ MORE >

Vocal AI can sub for professionals to give and grade elderly cognitive exams

When paired with willing older adults, talking AI can administer and assess preliminary dementia tests in much the same way—and with similar effectiveness—as human specialists.

READ MORE >
artificial intelligence AI cognitive tests seniors dementia
Share on Twitter Share on Facebook Share on Linkedin

Vocal AI can sub for professionals to give and grade elderly cognitive exams

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI cognitive tests seniors dementia
When paired with willing older adults, talking AI can administer and assess preliminary dementia tests in much the same way—and with similar effectiveness—as human specialists.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Star Trek star's family awarded $13M | AI for cardiac amyloidosis | TAVR concerns | New CKM syndrome guidelines
A brand new payment model | Cardiologist compensation keeps rising | Major medtech player invests $1.5B in TAVR tech
Death after TAVR: New data support a change | Rural hospital in spotlight for wrong reason | Heart changes linked to cancer risk
Physicians push back after government report | Device recalled | A lesson for PAD patients | AI for long-term stroke risk
The pros & cons of direct-to-patient drug programs | Why PAD patients should listen to their doctors
Coffee linked to major heart risk | Ablations in ASCs | Catheters recalled | A closer look at PFA | GLP-1 drugs & AFib
New guidelines for cardiovascular-kidney-metabolic syndrome and M-TEER | HF cell therapy company raises $4.4 million

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup